The Allergen Reduction and Child Health Study (ARCHS)

Part of paid clinical trials in New Orleans, Louisiana.

Sponsor
Tulane University
Study ID
NCT04331353
Status
Recruiting
Apply to this trial

Conditions

  • Asthma in Children

Eligibility Criteria

Sex
ALL
Age
5 Years - 17 Years
Healthy Volunteers
Not accepted

Interventions

  • Comparator 1 (tailored approach) — BEHAVIORAL
    Tailored to a child's sensitization status. Components include, education, cockroach baiting, mattress and bed covers, high efficiency particulate air (HEPA) vacuum cleaner, air purifier.
  • Comparator 2 (insecticidal bait) — BEHAVIORAL
    Cockroach bait

Study Details

The Allergen Reduction and Child Health Study (ARCHS) is a 12-month, two group randomized control trial of children with asthma and who are exposed to cockroaches. Children ages 5 - 17 living in the Greater New Orleans area will be recruited from a variety of clinic and community settings. The overall goal of the study is to improve patient-centered asthma outcomes (asthma symptom days, health care utilization, asthma control and quality of life) by targeting one key allergen - cockroach exposure in the child's home. The investigators propose a simple intervention of insecticidal bait that is low cost, simple to implement, and which is lower toxicity than other forms of pest control. The reduction in the number of cockroaches in the home is an environmental outcome that is patient-centered and is likely to add to its acceptance by families of children with asthma.

Key Dates

Start date
Nov 15, 2020
Status verified
Sep 2025
Primary completion
Apr 30, 2028
Completion
Apr 30, 2028

Study Design

Enrollment
290 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Active Comparator: Comparator 1 (tailored approach)
    Multi-component intervention tailored to the participant's allergic profile.
  • Active Comparator: Comparator 2 (insecticidal bait)
    Insecticidal bait for cockroach reduction.

Primary Outcome Measure

Maximum number of symptom days in the previous two weeks [ Time Frame: 12 Months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Tulane UniversityNew OrleansLouisiana70112
Derek W Werthmann, MPH
[email protected]
5049882386
Felicia A Rabito, PhD (PRINCIPAL_INVESTIGATOR)

Find similar trials in New Orleans, LA

By research site
Tulane University· New Orleans, LA

Related Studies